TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: 36nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: 36nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: 37nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: 100nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: 110nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: 117nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: 407nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: 710nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: 2.12E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: >5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: >5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: >5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: >5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Madrigal Pharmaceuticals
US Patent
Madrigal Pharmaceuticals
US Patent
Affinity DataIC50: >5.00E+3nMAssay Description:HER2 has emerged as a key target for anticancer drugs due to its intrinsic involvement in the phosphatidylinositol-3-kinase-Akt/protein kinase B (PI3...More data for this Ligand-Target Pair